Key Insights

Highlights

Treatment Research

1 treatments under study, led by Jwk002

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06345898Early Phase 1RecruitingPrimary

Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)

Showing all 1 trials

Research Network

Common Treatments

  • Jwk0021

Active Sponsors

  • West China Hospital1

Top Investigators

Activity Timeline